1.Fingerprint Establishment of Amino Acids Composition of Jinlong Capsule
Chinese Journal of Information on Traditional Chinese Medicine 2014;(3):62-64
Objective To establish the fingerprint of amino acids composition of Jinlong capsule. Methods Using 6-acetamido-4-hydroxy-2-methyl quinoline (AQC) as the derivating agent, 17 kinds of amino acids were analyzed by UPLC at the same time and the fingerprint of amino acids composition of Jinlong capsule was established. Result Totally 22 co-possessing peaks were selected as the fingerprint peaks, 17 kinds of amino acids were identified. The fingerprint similarity value of 10 batches was above 0.9. Conclusion The fingerprint is characteristic and can be used for the quality control of Jinlong capsule.
2.Fibroblastic reticular cell tumor: report of a case.
Chinese Journal of Pathology 2011;40(8):563-564
Abdominal Neoplasms
;
metabolism
;
pathology
;
Adolescent
;
Diagnosis, Differential
;
Fibroblasts
;
metabolism
;
pathology
;
Groin
;
Histiocytoma, Malignant Fibrous
;
metabolism
;
pathology
;
Humans
;
Keratins
;
metabolism
;
Lymph Nodes
;
metabolism
;
pathology
;
Lymphoma
;
metabolism
;
pathology
;
Male
;
Melanoma
;
metabolism
;
pathology
;
Vimentin
;
metabolism
3.Role of Cripto-1 protein in development and target therapy of breast cancer.
Ting LEI ; Xiao-jing GUO ; Li FU
Chinese Journal of Pathology 2010;39(1):66-68
Animals
;
Antibodies, Monoclonal
;
metabolism
;
therapeutic use
;
Biomarkers, Tumor
;
metabolism
;
Breast Neoplasms
;
metabolism
;
pathology
;
therapy
;
Drug Delivery Systems
;
Epidermal Growth Factor
;
immunology
;
metabolism
;
physiology
;
Epithelial-Mesenchymal Transition
;
GPI-Linked Proteins
;
Humans
;
Immunotherapy
;
methods
;
Intercellular Signaling Peptides and Proteins
;
Membrane Glycoproteins
;
immunology
;
metabolism
;
physiology
;
Neoplasm Invasiveness
;
Neoplasm Metastasis
;
Neoplasm Proteins
;
immunology
;
metabolism
;
physiology
5.Antiarrhythmic effect of TJ0711.
Xiao-Jing ZHANG ; Jun QIU ; Gao LI
Acta Pharmaceutica Sinica 2014;49(3):419-426
To study the antiarrhythmic effect of the newly developed alpha/beta-blocker TJ0711, a variety of animal models of arrhythmia were induced by CaCl2, ouabain and ischemia/reperfusion. Glass microelectrode technique was used to observe action potentials of right ventricular papillary muscle of guinea pig. The onset time of arrhythmia induced by CaCl2 was significantly prolonged by TJ0711 at 0.75, 1.5 and 3 mg x kg(-1) doses. TJ0711 (1.5 and 3 mg x kg(-1)) can significantly shorten the ventricular tachycardia (VT) and ventricular fibrillation (VF) duration, the incidence of VF and mortality were significantly reduced. On ischemia-reperfusion-induced arrhythmic model, TJ0711 (0.25, 0.5, 1 and 2 mg x kg(-1)) can significantly reduce the ventricular premature contraction (PVC), VT, VF incidence, mortality, arrhythmia score with a dose-dependent manner. At the same time, rats serum lactate dehydrogenase (LDH) and creatine kinase (CK) activities decreased significantly by TJ0711 (1 and 2 mg x kg(-1)). Ouabain could cause arrhythmia in guinea pigs, when TJ0711 (0.375, 0.75, 1.5 and 3 mg x kg(-1)) was given, the doses of ouabain inducing a variety of arrhythmia PVC, VT, VF, cardiac arrest (CA) were significantly increased with a dose-dependent manner. In the TJ0711 0.1-30 micromol x L(-1) concentration range, guinea pig right ventricular papillary muscle action potential RP (rest potential), APA (action potential amplitude) and V(max) (maximum velocity of depolarization) were not significantly affected. APD20, APD50 and APD90 had a shortening trend but no statistical difference with the increase of TJ0711 concentration. TJ0711 has antiarrhythmic effect on the sympathetic nerve excitement and myocardial cell high calcium animal arrhythmia model. Myocardial action potential zero phase conduction velocity and resting membrane potential were not inhibited by TJ0711. APD20, APD50 and APD90 were shortened by TJ0711 at high concentration. Its antiarrhythmic action mechanism may be besides the action of blocking beta1 receptor, may also have a strong selective blocking action on alpha1 receptor and reducing intracellular calcium concentration.
Action Potentials
;
drug effects
;
Adrenergic alpha-Antagonists
;
administration & dosage
;
pharmacology
;
Adrenergic beta-Antagonists
;
administration & dosage
;
pharmacology
;
Animals
;
Anti-Arrhythmia Agents
;
administration & dosage
;
pharmacology
;
Arrhythmias, Cardiac
;
blood
;
chemically induced
;
etiology
;
pathology
;
physiopathology
;
Calcium Chloride
;
Creatine Kinase
;
blood
;
Dose-Response Relationship, Drug
;
Female
;
Guinea Pigs
;
Heart Ventricles
;
cytology
;
Lactate Dehydrogenases
;
blood
;
Male
;
Myocardial Reperfusion Injury
;
complications
;
Myocytes, Cardiac
;
drug effects
;
physiology
;
Ouabain
;
Papillary Muscles
;
cytology
;
Phenoxypropanolamines
;
administration & dosage
;
pharmacology
;
Random Allocation
;
Rats
;
Rats, Sprague-Dawley
7.Receptor for activated C kinase 1 and neoplasms
Xiuping LI ; Mingming XIAO ; Shibing JING
Journal of International Oncology 2012;39(9):662-664
As an anchoring protein,receptor for activated C kinase 1 ( RACK1 ) can combine together with many kinds of intracellular signaling molecules and participate in many signal conduction in cells.Researchers have paid close attention to the role of RACK1 in signal transduction molecule network of tumor cells.Abundant studies reveal that RACK1 can regulate signal transduction by regulating tumorigenesis and immune escape in tumor cells,and then play important roles.
8.The Expression of MMP-2 in EAM and the Effects of Methylprednisolone
Ning ZHANG ; Bo XIAO ; Jing LI
Journal of Chinese Physician 2001;0(09):-
Objective To investigate the effect of matrix metalloproteinase(MMP-2) in the attack of exprimental autoimmune myositis(EAM) rats, and the effects of methylprednisolone on expressions of gene mRNA and protein of MMP-2. Methods The expression levels of MMP-2 in the peripheral blood, spleen lymphocytes and muscles were detected by using RT-PCR and immunohistochemistry techniques and was compared among EAM group,EAM with methylprednisolone treatment group (EAMM) and control group. Results ⑴ The degree of episode in EAMM group was lower than that of EAM group , and the infiltration of the inflammatory cells and the necrosis of the muscles were also mild in EAMM group. ⑵There was significant upregulation of the expression of the MMP-2 gene mRNA in the lymphocytes of peripheral bood and spleen of EAM rats as compared with that of the control,Elevation of the expression of MMP-2 protein in rats muscles tissues of EAMM group was observed obviously. However, the expression of the mRNA and the protein of MMP-2 was suppressed significantly in EAM group compared with control group. Conclusions The upregulation of the expression of MMP-2 may be correlated with the onset of EAM. Methylprednisolone may relieve the degree of the pathology of EAM by the downregulation of MMP-2 .
9.Current progression and prospect in the targeting therapy of age-related macular degeneration
Chinese Journal of Experimental Ophthalmology 2012;30(1):1-6
Age-related macular degeneration (AMD) has become a leading cause of irreversible visual loss in senior population and a serious issue of public health as the aging of society worldwide,especially wet AMD.Wet AMD is characterized by choroidal neovascularization(CNV)with a rapidly developing process andsevere impairment of visual acuity.The effective therapy that can destroy choroidal neovascularization and improve visual acuity for very long time is lack.In the recent 20 years,more attentions focuse on the treatment of choroidal neovascularization.From bench to bedside,the research on targeted treatment of angiogenesis brings the bloom of wet AMD medical therapy.This paper will summarize the update information of wet AMD.